Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for EQS from our risk checks.
Equasens Société anonyme Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €65.60 |
52 Week High | €85.80 |
52 Week Low | €46.15 |
Beta | 0.90 |
1 Month Change | 13.10% |
3 Month Change | 32.26% |
1 Year Change | -18.20% |
3 Year Change | -26.95% |
5 Year Change | 11.56% |
Change since IPO | 1,439.91% |
Recent News & Updates
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Recent updates
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?
Dec 01Shareholder Returns
EQS | FR Healthcare Services | FR Market | |
---|---|---|---|
7D | 1.1% | -0.5% | -1.4% |
1Y | -18.2% | -2.9% | 6.8% |
Return vs Industry: EQS underperformed the French Healthcare Services industry which returned -2.9% over the past year.
Return vs Market: EQS underperformed the French Market which returned 6.8% over the past year.
Price Volatility
EQS volatility | |
---|---|
EQS Average Weekly Movement | 4.8% |
Healthcare Services Industry Average Movement | 5.4% |
Market Average Movement | 4.5% |
10% most volatile stocks in FR Market | 9.4% |
10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: EQS's share price has been volatile over the past 3 months.
Volatility Over Time: EQS's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 1,271 | Denis Supplisson | equasens.com |
Equasens Société anonyme provides healthcare IT solutions in Europe. It offers id. PATIENT, a business software; id.
Equasens Société anonyme Fundamentals Summary
EQS fundamental statistics | |
---|---|
Market cap | €986.05m |
Earnings (TTM) | €47.05m |
Revenue (TTM) | €219.79m |
21.0x
P/E Ratio4.5x
P/S RatioIs EQS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EQS income statement (TTM) | |
---|---|
Revenue | €219.79m |
Cost of Revenue | €149.91m |
Gross Profit | €69.88m |
Other Expenses | €22.83m |
Earnings | €47.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 27, 2024
Earnings per share (EPS) | 3.13 |
Gross Margin | 31.79% |
Net Profit Margin | 21.41% |
Debt/Equity Ratio | 25.7% |
How did EQS perform over the long term?
See historical performance and comparison